RMD Open
2 stories
-
healthReal-World Study Validates Tocilizumab Efficacy for Systemic Sclerosis Treatment
A French-Italian study confirms tocilizumab stabilizes lung function and improves skin and joint outcomes in systemic sclerosis patients, supporting its role as a disease-modifying therapy.
-
healthNovel PET Tracer Emerges as Precision Biomarker for Giant Cell Arteritis
A first-in-human study identifies a new VAP-1 targeting PET tracer that accurately tracks vascular inflammation and treatment response in giant cell arteritis patients.